These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 14526190
1. Mechanisms of neuronal cell death in Huntington's disease. Sawa A, Tomoda T, Bae BI. Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190 [Abstract] [Full Text] [Related]
2. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Reddy PH, Charles V, Williams M, Miller G, Whetsell WO, Tagle DA. Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1035-45. PubMed ID: 10434303 [Abstract] [Full Text] [Related]
3. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS, Logvinova AV, Peel AL, Chen SF, Hook V, Singaraja R, Krajewski S, Goldsmith PC, Ellerby HM, Hayden MR, Bredesen DE, Ellerby LM. Cell Death Differ; 2004 Apr 29; 11(4):424-38. PubMed ID: 14713958 [Abstract] [Full Text] [Related]
4. Towards a transgenic model of Huntington's disease in a non-human primate. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW. Nature; 2008 Jun 12; 453(7197):921-4. PubMed ID: 18488016 [Abstract] [Full Text] [Related]
6. Genetics and neuropathology of Huntington's disease. Reiner A, Dragatsis I, Dietrich P. Int Rev Neurobiol; 2011 Jun 12; 98():325-72. PubMed ID: 21907094 [Abstract] [Full Text] [Related]
7. Pathogenic mechanisms in Huntington's disease. Jones L, Hughes A. Int Rev Neurobiol; 2011 Jun 12; 98():373-418. PubMed ID: 21907095 [Abstract] [Full Text] [Related]
9. Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria? Sawa A. J Mol Med (Berl); 2001 Jul 12; 79(7):375-81. PubMed ID: 11466559 [Abstract] [Full Text] [Related]
12. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Kenney C, Powell S, Jankovic J. Mov Disord; 2007 Jan 12; 22(1):127-30. PubMed ID: 17115386 [Abstract] [Full Text] [Related]
13. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC. Hum Mol Genet; 2001 Aug 15; 10(17):1829-45. PubMed ID: 11532992 [Abstract] [Full Text] [Related]
14. Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown. Cheng HM, Chern Y, Chen IH, Liu CR, Li SH, Chun SJ, Rigo F, Bennett CF, Deng N, Feng Y, Lin CS, Yan YT, Cohen SN, Cheng TH. PLoS Genet; 2015 Mar 15; 11(3):e1005043. PubMed ID: 25760041 [Abstract] [Full Text] [Related]
15. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ. J Biol Chem; 2010 Apr 02; 285(14):10653-61. PubMed ID: 20145253 [Abstract] [Full Text] [Related]
16. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. de Almeida LP, Ross CA, Zala D, Aebischer P, Déglon N. J Neurosci; 2002 May 01; 22(9):3473-83. PubMed ID: 11978824 [Abstract] [Full Text] [Related]